Navigating market access pathways can be just as critical as regulatory approval for digital health providers. Relying on case studies, we’ll explore the choice of the first non-domestic market for young companies. When reaching this key stage in development, is there a country in the EU that could guarantee a better launch? What aspects should be considered to ensure a digital health solution is financially viable within a healthcare system and well positioned in a target market? What tools and collaborations can start-ups leverage to maximise their chance of success?